PATUSKY CHRISTOPHER

Christopher Patusky's Form 4 record at United Therapeutics runs 358 transactions from June 2004 through July 2026, all against a single issuer. Across that entire span, only 21 shares were ever bought — against 327,676 sold. That lopsided 21-share exception is the only accumulation event in an otherwise uninterrupted stream of option exercises converted into same-day sales.

The exercises themselves reveal two distinct strike prices still active in his holdings: $101.80, used for a 1,000-share exercise on 2026-04-17 that was sold the same day at $578.88, and for two 650-share exercises on 2026-07-09 with no accompanying sale yet reported; and $175.43, used for a 5,000-share exercise on 2025-03-19 whose proceeds were sold across seven same-day tranches — 100, 1,299, 736, 457, 328, 1,780, and 300 shares between $313.77 and $307.73 — a set that sums to exactly the 5,000 shares exercised. A third exercise size shows up on 2025-01-10: another 5,000-share tranche at $175.43, this one only partially visible here (109, 1,092, and 1,930 shares sold at $363.86, $362.95, and $362.03). The exercise sizes have shrunk over time — from 5,000-share tranches in early 2025 down to 1,000 and 650 shares by mid-2026.